Gene: CAMK2N1

55450
PRO1489
calcium/calmodulin dependent protein kinase II inhibitor 1
protein-coding
1p36.12
Ensembl:ENSG00000162545 MIM:614986 Vega:OTTHUMG00000002837 UniprotKB:Q7Z7J9
NC_000001.11
PubMed
AD
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
1.415e-2 (AD)  7.477e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
GNB10.924
AES0.921
CA110.911
PDZD40.904
OLFM10.899
SOBP0.894
WSB20.894
CALM10.893
BRSK10.893
NSMF0.892

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.795
OR4F29-0.782
C1orf87-0.314
CLEC4E-0.267
PTPN7-0.263
CCR2-0.261
CDA-0.257
CR1-0.256
GJA3-0.254
CXCR2-0.254

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C5486512-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of CAMK2N1 mRNA19933214
C0297902,2',3',4,4',5-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAMK2N1 mRNA"25510870
C0294972,3-bis(3'-hydroxybenzyl)butyrolactone"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2N1 mRNA"19167446
C0817662,4,4'-trichlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAMK2N1 mRNA"25510870
C0140242,4,5,2',4',5'-hexachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAMK2N1 mRNA"25510870
C0098282,4,5,2',5'-pentachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAMK2N1 mRNA"25510870
C0164032,4-dinitrotoluene"2,4-dinitrotoluene affects the expression of CAMK2N1 mRNA"21346803
C0094072,5,2',5'-tetrachlorobiphenyl"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAMK2N1 mRNA"25510870
C0284513,4,3',4'-tetrachlorobiphenyl"3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of CAMK2N1 mRNA]"19467301
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of CAMK2N1 mRNA22230336
D000082AcetaminophenAcetaminophen affects the expression of CAMK2N1 mRNA17562736
D000447AldehydesAldehydes results in decreased expression of CAMK2N1 mRNA25014914
C015001arsenitearsenite results in decreased methylation of CAMK2N1 promoter23974009
D004958Estradiol[Estradiol co-treated with Progesterone] results in decreased expression of CAMK2N1 mRNA20660070
D004958EstradiolEstradiol results in decreased expression of CAMK2N1 mRNA16474171|1916744
C006780bisphenol Abisphenol A results in decreased expression of CAMK2N1 mRNA16474171
C006780bisphenol Abisphenol A affects the expression of CAMK2N1 mRNA25181051
C005961bis(tri-n-butyltin)oxidebis(tri-n-butyltin)oxide results in increased expression of CAMK2N1 mRNA25270620
D0151248-Bromo Cyclic Adenosine Monophosphate8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CAMK2N1 mRNA22079614
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in increased expression of CAMK2N1 mRNA15336504
C018475butyraldehydebutyraldehyde results in decreased expression of CAMK2N1 mRNA26079696
C584509C646 compoundC646 compound results in decreased expression of CAMK2N1 mRNA26191083
D002220CarbamazepineCarbamazepine affects the expression of CAMK2N1 mRNA25979313
D002251Carbon TetrachlorideCarbon Tetrachloride affects the expression of CAMK2N1 mRNA17484886
D020111Chlorodiphenyl (54% Chlorine)Chlorodiphenyl (54% Chlorine) results in increased expression of CAMK2N1 mRNA25270620
D020245p-Chloromercuribenzoic Acid"[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
D020245p-Chloromercuribenzoic Acidp-Chloromercuribenzoic Acid results in decreased expression of CAMK2N1 mRNA26272509
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CAMK2N1 gene20938992
C074702chromium hexavalent ionchromium hexavalent ion affects the expression of CAMK2N1 mRNA28472532
C018021cobaltous chloridecobaltous chloride results in decreased expression of CAMK2N1 mRNA19320972
D003375Coumestrol"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2N1 mRNA"19167446
D003375Coumestrol[Coumestrol co-treated with resveratrol] results in decreased expression of CAMK2N1 mRNA19167446
D003375CoumestrolCoumestrol results in decreased expression of CAMK2N1 mRNA19167446
D003471CuprizoneCuprizone results in decreased expression of CAMK2N1 mRNA26577399
D016572CyclosporineCyclosporine results in decreased expression of CAMK2N1 mRNA20106945
D016572CyclosporineCyclosporine results in decreased expression of CAMK2N1 mRNA19770486
D003561CytarabineCytarabine results in increased expression of CAMK2N1 mRNA21198554
C014347decitabinedecitabine affects the expression of CAMK2N1 mRNA23300844
D002945CisplatinCisplatin affects the expression of CAMK2N1 mRNA23300844
D002945CisplatinCisplatin results in decreased expression of CAMK2N1 mRNA27392435
D004041Dietary Fats"3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of CAMK2N1 mRNA]"19467301
D004041Dietary FatsDietary Fats results in increased expression of CAMK2N1 mRNA18042831|1946730
C118739entinostatentinostat results in decreased expression of CAMK2N1 mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of CAMK2N1 mRNA17557909
C082360fipronilfipronil results in increased expression of CAMK2N1 mRNA23962444
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CAMK2N1 gene20938992
C039281furanfuran results in increased expression of CAMK2N1 mRNA26194646
D019833GenisteinGenistein results in decreased expression of CAMK2N1 mRNA16474171
C004312glycidolglycidol results in decreased expression of CAMK2N1 mRNA24915197
D006534Heptachlor EpoxideHeptachlor Epoxide results in increased expression of CAMK2N1 mRNA25270620
D017313FenretinideFenretinide results in increased expression of CAMK2N1 mRNA28973697
C016517indole-3-carbinolindole-3-carbinol affects the expression of CAMK2N1 mRNA21396975
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CAMK2N1 mRNA25613284
D007854LeadLead affects the expression of CAMK2N1 mRNA28903495
C042720mercuric bromidemercuric bromide results in decreased expression of CAMK2N1 mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
D008701MethapyrileneMethapyrilene results in increased expression of CAMK2N1 mRNA22484513
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CAMK2N1 gene20938992
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of CAMK2N1 mRNA28001369
D008942MitoxantroneCAMK2N1 protein affects the susceptibility to Mitoxantrone16217747
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of CAMK2N1 mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of CAMK2N1 mRNA"25554681|2562005
D009532NickelNickel results in decreased expression of CAMK2N1 mRNA25583101
D000073878Palm OilPalm Oil results in increased expression of CAMK2N1 mRNA18042831
C410127PCB 180"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CAMK2N1 mRNA"25510870
C086401pentabromodiphenyl etherpentabromodiphenyl ether results in increased expression of CAMK2N1 mRNA26705709
C046012pentanalpentanal results in decreased expression of CAMK2N1 mRNA26079696
D010634PhenobarbitalPhenobarbital affects the expression of CAMK2N1 mRNA19159669
D010634PhenobarbitalPhenobarbital affects the expression of CAMK2N1 mRNA23091169
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in decreased expression of CAMK2N1 mRNA26272509
D011078Polychlorinated BiphenylsPolychlorinated Biphenyls analog results in decreased expression of CAMK2N1 mRNA16474171
D011192Potassium DichromatePotassium Dichromate results in increased expression of CAMK2N1 mRNA23608068
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile results in increased expression of CAMK2N1 mRNA19162173
D011374Progesterone[Estradiol co-treated with Progesterone] results in decreased expression of CAMK2N1 mRNA20660070
C045950propiconazolepropiconazole results in decreased expression of CAMK2N1 mRNA21278054
C005556propionaldehydepropionaldehyde results in decreased expression of CAMK2N1 mRNA26079696
D011441PropylthiouracilPropylthiouracil results in decreased expression of CAMK2N1 mRNA24780913
C059514resveratrol[Coumestrol co-treated with resveratrol] results in decreased expression of CAMK2N1 mRNA19167446
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of CAMK2N1 mRNA25895662
D053260SootSoot results in decreased expression of CAMK2N1 mRNA26551751
C020806tetrabromobisphenol Atetrabromobisphenol A results in decreased expression of CAMK2N1 mRNA27914987
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of CAMK2N1 mRNA21570461|2637764
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of CAMK2N1 mRNA16214954
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of CAMK2N1 mRNA19933214|2629044
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CAMK2N1 mRNA25613284
D014212TretinoinTretinoin results in increased expression of CAMK2N1 mRNA21934132|2372400
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
C012589trichostatin Atrichostatin A results in decreased expression of CAMK2N1 mRNA24935251|2627250
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of CAMK2N1 mRNA25979313
D014635Valproic AcidValproic Acid results in decreased expression of CAMK2N1 mRNA23179753|2493525
D014635Valproic AcidValproic Acid results in increased expression of CAMK2N1 mRNA19101580
D014635Valproic AcidValproic Acid affects the expression of CAMK2N1 mRNA17963808
D001335Vehicle EmissionsVehicle Emissions results in decreased methylation of CAMK2N1 gene25560391
C025643vinclozolinvinclozolin affects the expression of CAMK2N1 mRNA19015723
D024483Vitamin K 3Vitamin K 3 affects the expression of CAMK2N1 mRNA20044591
C088658zoledronic acidzoledronic acid results in decreased expression of CAMK2N1 mRNA24714768

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0008427calcium-dependent protein kinase inhibitor activity-IMP18305109  
GO:0019901protein kinase binding-IPI18305109  
GO ID GO Term Qualifier Evidence PubMed
GO:0006469negative regulation of protein kinase activity-IMP18305109  
GO:0008285negative regulation of cell proliferation-IMP18305109  
GO:0010628positive regulation of gene expression-IMP18305109  
GO:0045786negative regulation of cell cycle-IMP18305109  
GO:0045861negative regulation of proteolysis-IMP18305109  
GO:0070373negative regulation of ERK1 and ERK2 cascade-IMP18305109  
GO:1904030negative regulation of cyclin-dependent protein kinase activity-IMP18305109  
GO ID GO Term Qualifier Evidence PubMed
GO:0005622intracellular-IDA18305109  
GO:0014069postsynaptic density-IEA-  
GO:0030054cell junction-IEA-  
GO:0030425dendrite-IEA-  
GO:0043025neuronal cell body-IEA-  
GO:0045211postsynaptic membrane-IEA-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
28714806Loss of control over the ethanol consumption: differential transcriptional regulation in prefrontal cortex. (2017 Sep)de Paiva Lima CJ Neurogenet